SEARCH

SEARCH BY CITATION

References

  • Almeida, A.M., Khair, K., Hann, I. & Liesner, R. (2003) The use of recombinant factor VIIa in children with inherited platelet function disorders. British Journal of Haematology, 121, 477481.
  • Avila, M.A., Jacyntho, C. & Santos, M.L. (1992) Syndrome de Bernard-Soulier et grossesse; un cas. Journal of Gynaecology, Obstetrics and Reproductive Biology Paris, 21, 7374.
  • Aydinok, Y., Egemen, A. & Balkan, C. (2007) Menorrhagia due to abnormalities of the platelet function: evaluation of two young patients. Pediatrics International, 49, 106108.
  • BCSH (2003) Guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 1023.
  • Bell, J.A. & Savidge, G.F. (2003) Glanzmann’s thrombasthenia proposed optimal management during surgery and delivery. Clinical and Applied Thrombosis/Hemostasis, 9, 167170.
  • Bellucci, S. & Caen, J. (2002) Molecular basis of Glanzmann’s thrombasthenia and current strategies in treatment. Blood Reviews, 16, 193202.
  • Bellucci, S., Devergie, A., Gluckman, E., Tobelem, G., Lethielleux, P., Benbunan, M., Schaison, G. & Boiron, M. (1985) Complete correction of Glanzmann’s thrombasthenia by allogeneic bone marrow transplantation. British Journal of Haematology, 59, 635641.
  • Bellucci, S., Damaj, G., Boval, B., Rocha, V., Devergie, A., Yacoub Agha, I., Garderet, L., Ribaud, P., Traineau, R., Socie′, G. & Gluckman, E. (2000) Bone marrow transplantation in severe Glanzmann’s thrombasthenia with antiplatelet alloimmunization. Bone Marrow Transplantation, 25, 327330.
  • Berndt, M.C., Gregory, C., Chong, B.H., Zola, H. & Castaldi, P.A. (1983) Additional glycoprotein defects in Bernard-Soulier’s syndrome: confirmation of genetic basis by parental analysis. Blood, 62, 800807.
  • Bolton-Maggs, P.H.B., Chalmers, E.A., Collins, P.W., Harrison, P., Kitchen, S., Liesner, R.J., Minford, A., Mumford, A., Parapia, L.A., Perry, D.J., Watson, S.P., Wilde, J.T. & Williams, M.D. (2006) A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. British Journal of Haematology, 135, 603633.
  • Boval, B., Bellucci, S. & Boyer-Neumann, C.. (2001) Glanzmann’s thrombasthenia and pregnancy: clinical observations and management of four affected women. Thrombosis and Haemostasis, 2001(Suppl), (Abstract) 1154.
  • Capuzzo, E., Polatti, F. & Zara, C. (1997) Glanzmann’s Thrombasthenia and puerperium. International Journal of Gynaecology & Obstetrics, 57, 313314.
  • Ten Cate, H., Bauer, K.A., Levi, M., Edgington, T.S., Sublett, R.D., Barzegar, S., Kass, B.L. & Rosenberg, R.D. (1993) The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. The Journal of Clinical Investigation, 92, 12071212.
  • Cattaneo, M. (2002) Desmopressin in the treatment of patients with defects of platelet function. Haematologica, 87, 11221124.
  • Cattaneo, M., Zighetti, M.L., Lombardi, R. & Mannucci, P.M. (1994) Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP. British Journal of Haematology, 88, 826829.
  • Chuansumrit, A., Sangapreecha, C. & Hathirat, P. (1999) Successful epistaxis control in a patient with Glanzmann’s thrombasthenia by increased bolus injection dose of recombinant factor VIIa. Thrombosis and Haemostasis, 82, 1778.
  • Chuansumrit, A., Suwannuraks, M., Sri-Udomporn, N., Pongtanakul, B. & Worapongpaiboon, S. (2003) Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagulation & Fibrinolysis, 14, 187190.
  • Clemetson, K.J., McGregor, J.L., James, E., Dechavanne, M. & Luscher, E.F. (1982) Characterization of the platelet membrane glycoprotein abnormalities in Bernard Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. The Journal of Clinical Investigation, 70, 304311.
  • Connor, P., Khair, K., Liesner, R., Amrolia, P., Veys, P., Ancliff, P. & Mathias, M. (2008) Stem cell transplantation for children with Glanzmann thrombasthenia. British Journal of Haematology, 140, 568571.
  • Coppola, A. & Di Minno, G. (2008) Desmopressin in inherited disorders of platelet function. Haemophilia, 14(Suppl. 1), 3139.
  • Cuthbert, R.J., Watson, H.H.K., Handa, S.I., Abbott, I. & Ludlam, C.A. (1988) DDAVP shortens the bleeding time in Bernard–Soulier syndrome. Thrombosis Research, 49, 649.
  • Dargaud, Y. (2006) A case of glanzmann’s thrombasthenia successfully treated with recombinant factor VIIa during a surgical procedure: observations on the monitoring and the mechanism of action of this drug. Haematologica, 91 (Suppl. 6), ECR 20.
  • Dede, M., Ural, A.U., Yenen, M., Mesten, Z. & Baser, I. (2007) Glanzmann’s thrombasthenia in two pregnant females. American Journal of Hematology, 82, 330331.
  • Di Michele, D.M. & Hathaway, W.E. (1990) Use of DDAVP in inherited and acquired platelet dysfunction. American Journal of Hematology, 33, 3945.
  • Diamandis, M., Velijkoviv, D.K., Maurer-Spurej, E., Rivard, G.E. & Hayward, C.P.M. (2008) Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagulation and Fibrinolysis, 19, 109119.
  • Español, I., Hernández, A., Pujol, R.M., Urrutia, T. & Pujol-Moix, N. (1998) Type IV Ehlers-Danlos syndrome with platelet delta-storage pool disease. Annals of Hematology, 77, 4750.
  • Fang, J., Hodivala-Dilke, K., Johnson, B.D., Du, L.M., Hynes, R.O., White, G.C. & Wilcox, D.A. (2005) Therapeutic expression of the platelet-specific integrin, alphaIIb-beta3, in a murine model for Glanzmann thrombasthenia. Blood, 106, 26712679.
  • Flood, V.H., Johnson, F.L., Boshkov, L.K., Thomas, G.A., Nugent, D.J., Bakke, A.C., Nicholson, H.S., Tilford, D., Brown, M.P. & Godder, K.T. (2005) Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia. Pediatric Blood and Cancer, 45, 971975.
  • Fujimori, K., Ohto, H., Honda, S. & Sato, A. (1999) Antepartum diagnosis of fetal intracranial hemorrhage due to maternal Bernard–Soulier syndrome. Obstetrics and Gynecology, 94, 817819.
  • Fujimoto, T.T., Kishimoto, M., Ide, K., Mizushima, M., Mita, M., Sezaki, N., Kojima, K., Shinagawa, K., Niiya, K., Tanimoto, M. & Fujimura, K. (2005) Glanzmann thrombasthenia with acute myeloid leukemia successfully treated by bone marrow transplantation. International Journal of Hematology, 81, 7780.
  • George, J.N., Caen, J.P. & Nurden, A.T. (1990) Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood, 75, 13831395.
  • Hayward, C.P. (2005) Diagnosis and management of mild bleeding disorders. Hematology, 2005, 423428.
  • Hayward, C.P.M., Rao, A.K. & Cattaneo, M. (2006) Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia, 12, 128136.
  • Heslop, H.E., Hickton, C.M., Laird, E., Tait, J.D., Doig, J.R. & Beard, M.E.J. (1986) Twin pregnancy and parturition in a patient with Bernard–Soulier Syndrome. Scandinavian Journal of Haematology, 37, 7173.
  • Ishaqi, M.K., El-Hayek, M., Gassas, A., Khanani, M., Trad, O., Baroudi, M. & Jamil, A. (2009) Allogeneic stem cell transplantation for Glanzmann Thrombasthenia. Pediatric Blood & Cancer, 52, 682683.
  • Jallu, V., Bianchi, F. & Kaplan, C. (2005) Fetal-neonatal alloimmune thrombocytopenia and unexpected Glanzmann thrombasthenia carrier: report of two cases. Transfusion, 45, 550553.
  • Johnson, A., Goodall, A.H., Downie, C.J., Vellodi, A. & Michael, D.P. (1994) Bone marrow transplantation for Glanzmann’s thrombasthenia. Bone Marrow Transplantation, 14, 147150.
  • Kadir, R.A., Lee, C.A., Sabin, C.A., Pollard, D. & Economides, D.L. (2002) DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study. Haemophilia, 8, 787793.
  • Kahr, W.H.A., Zheng, S., Sheth, P.M., Pai, M., Cowie, A., Bouchard, M., Podor, T.J., Rivard, G.E. & Hayward, C.P.M. (2001) Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood, 98, 257265.
  • Kale, A., Bayhan, G., Yalinkaya, A. & Yayla, M. (2004) The use of recombinant factor VIla in a primigravida with Glanzmann’s thrombasthenia during delivery. Journal of Perinatal Medicine, 32, 456458.
  • Kashyap, R., Kriplani, A., Saxena, R., Takkar, D. & Choudhry, V.P. (1997) Pregnancy in a patient of Glanzmann’s thrombasthenia with antiplatelet antibodies. The Journal of Obstetrics and Gynaecology Research, 23, 247250.
  • Khalil, A., Seoud, M., Tannous, R., Usta, I. & Shamseddine, A. (1998) Bernard–Soulier syndrome in pregnancy: case report and review of the literature. Clinical and Laboratory Haematology, 20, 125128.
  • Kopeć, I., Maślanko, K., Litmanowicz, M., Stefańska, E., Mikos, A. & Warzocha, K. (2005) Bernard–Soulier syndrome during pregnancy: a case report. Ginekologia Polska, 76, 824827.
  • Kosch, A., Kehrel, B., Nowak-Göttl, U., Häberle, J. & Jürgens, H. (1999) Thrombocytic alpha-delta-storage-pool-disease: shortening of bleeding time after infusion of 1-desamino-8-D-arginine vasopressin. Klinische Padiatrie, 211, 198200.
  • Kriplani, A., Singh, B.M., Sowbernika, R. & Choudhry, V.P. (2005) Successful pregnancy outcome in Bernard–Soulier syndrome. The Journal of Obstetrics and Gynaecology Research, 31, 5256.
  • Kunishima, S., Miura, H. & Fakutani, H. (1994) Bernard-Soulier Kagoshima: Ser 444 – stop mutation of the glycoprotein (gp) Ib alpha and surface expression of gpIb beta and gpIX. Blood, 84, 33563362.
  • Lethagen, S. & Nilsson, I.M. (1992) DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa. European Journal of Haematology, 49, 713.
  • Léticée, N., Kaplan, C. & Lémery, D. (2005) Pregnancy in mother with Glanzmann’s thrombasthenia and isoantibody against GPIIb-IIIa: is there a foetal risk? European Journal of Obstetrics, Gynecology and Reproductive Biology, 121, 139142.
  • Lisman, T., Mosnier, L.O., Lambert, T., Mauser-Bunschoten, E.P., Meijers, J.C.M., Nieuwenhuis, H.K. & De Groot, P.G. (2002) Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe haemophilia A. Blood, 99, 175179.
  • Lisman, T., Adelmeijer, J., Heijnen, H.F.G. & De Groot, P.G. (2004) Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor-independent fibrin generation. Blood, 103, 17201727.
  • Locatelli, F., Rossi, G. & Balduini, C. (2003) Hematopoietic stem-cell transplantation for the Bernard–Soulier syndrome. Annals of Internal Medicine, 138, 79.
  • Lopez, J.A., Andrews, R.K., Afshar-Kharghan, V. & Berndt, M.C. (1998) Bernard–Soulier Syndrome. Blood, 91, 43974418.
  • Lozano, M., Escolar, G., Bellucci, S., Monteagudo, J., Pico, M., Ordinas, A. & Caen, J.P. (1999) Hemostatic 1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard–Soulier syndrome: the role of factor VIII. Platelets, 10, 141145.
  • Makris, M., Conlon, C.P. & Watson, H.G. (2003) Immunization of patients with bleeding disorders. Haemophilia, 9, 541546.
  • Malhotra, N., Chanana, C. & Deka, D. (2006) Pregnancy in a patient of Glanzmann’s Thrombasthenia. Indian Journal of Medical Sciences, 60, 111113.
  • Mannucci, P.M. (1988) Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood, 72, 14491455.
  • Mannucci, P.M. (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood, 90, 25152521.
  • Markovitch, O., Ellis, M., Holzinger, M., Goldberger, S. & Beyth, Y. (1998) Severe juvenile vaginal bleeding due to Glanzmann’s thrombasthenia: case report and review of the literature. American Journal of Hematology, 57, 225227.
  • McColl, M.D. & Gibson, B.E.S. (1997) Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann’s thrombasthenia. British Journal of Haematology, 99, 5860.
  • Mhawech, P. & Saleem, A. (2000) Inherited giant platelet disorders. American Journal of Clinical Pathology, 113, 176190.
  • Michalas, S., Malamitsi-Puchner, A. & Tsevrenis, H. (1984) Pregnancy and delivery in Bernard–Soulier Syndrome. Acta Obstetrica et Gynecologica Scandinavica, 63, 185186.
  • Miller, J.L., Lyle, V.A. & Cunningham, D. (1992) Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood, 79, 439446.
  • Miller, W., Dunn, A. & Chiang, K.Y. (2009) Sustained engraftment and resolution of bleeding phenotype after unrelated cord blood hematopoietic stem cell transplantation for severe glanzmann thrombasthenia. Journal of Pediatric Hematology and Oncology, 31, 437439.
  • Mitsui, T., Yokoyama, S. & Yazaki, N. (1998) Severe bleeding tendency in a patient with Bernard-Soulier associated with a homozygous single base pair deletion in the gene coding for the human platelet glycoprotein Ib alpha. Journal of Pediatric Haematology & Oncology, 20, 246251.
  • Nieuwenhuis, H.K. & Sixma, J.J. (1988) 1-Desamino-8-D-arginine vasopressin (desmopressin) shortens the bleeding time in storage pool deficiency. Annals of Internal Medicine, 108, 6567.
  • Noda, M., Fujimura, K. & Takafuta, T. (1995) Heterogeneous expression of glycoprotein Ib, IX and V in platelets from two patients with Bernard–Soulier syndrome caused by different genetic abnormalities. Thrombosis & Haemostasis, 74, 14111415.
  • Nolan, B., White, B., Smith, J., O’reily, C., Fitzpatrick, B. & Smith, O.P. (2000) Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders. British Journal of Haematology, 109, 865869.
  • Novotny, V.M. (1999) Prevention and management of platelet transfusion refractoriness. Vox Sanguinis, 76, 113.
  • Nurden, A.T. (2006) Glanzmann thrombasthenia. Orphanet Journal of Rare Diseases, 1, 110.
  • Nurden, A.T. & George, J.N.. (2005) Haemostasis and Thrombosis, Basic Principles and Clinical Practice, 6th edn. Lippincott, Williams & Wilkins, Philadelphia, pp. 9871010.
  • Nurden, P. & Nurden, A.T. (2008) Congenital disorders associated with platelet dysfunctions. Thrombosis and Haemostasis, 99, 253263.
  • D’Oiron, R., Menart, C., Trzeciak, M.C., Nurden, P., Fressinaud, E., Dreyfus, M., Laurian, Y. & Negrier, C. (2000) Use of recombinant factor VIIa in 3 patients with inherited type 1 Glanzmann’s thrombasthenia undergoing invasive procedures. Thrombosis and Haemostasis, 83, 644647.
  • Patel, R.K., Savidge, G.F. & Rangarajan, S. (2001) Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann’s thrombasthenia and human leucocyte antigen antibodies. British Journal of Haematology, 114, 245246.
  • Patel, D., Vaananen, H., Jirouska, M., Hoffmann, T., Bodian, C. & Coller, B.S. (2003) Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood, 101, 929936.
  • Peaceman, A.H., Katz, A.R. & Laville, M. (1989) Bernard–Soulier Syndrome complicating pregnancy: a case report. Obstetrics and Gynaecology, 73, 457459.
  • Peng, T.C., Kickler, T.S., Bell, W.R. & Haller, E. (1991) Obstetric complications in a patient with Bernard–Soulier Syndrome. American Journal of Obstetrics and Gynaecology, 165, 425426.
  • Poon, M.C. (2007) Clinical use of rFVIIa in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia. Vascular Health Risk Management, 3, 655664.
  • Poon, M.C., Demers, C., Jobin, F. & Wu, J.W. (1999) Recombinant VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood, 94, 39513953.
  • Poon, M.C., D’Orion, R., Hann, I., Ne′grier, C., De Lumley, L., Thomas, A., Karafoulidou, A., Demers, C., Street, A., Huth-Kuhne, A., Petrini, P., Fressinaud, E., Morfini, M., Tengborn, L., Marque`s-Verdier, A., Musso, R., Devecioglu, O., Houston, D.S., Lethagen, S., Van Geet, C., Von Depka, M., Berger, C., Beurrier, P., Britton, H.A., Gerrits, W., Guthner, C., Kuhle, S., Lorenzo, J., Makris, P., Nohe, N., Paugy, P., Pautard, B., Torchet, M., Trillot, N., Vicariot, M., Wilde, J., Winter, M., Chambost, H., Ingerslev, J., Peters, M. & Strauss, G. (2001) Use of recombinant factor VIIa (Novoseven) in patients with Glanzmann thrombasthenia. Seminars in Haematology, 38, s21s25.
  • Poon, M.C., D’Oiron, R., Von Depka, M., Khair, K., Negrier, C., Karafoulidou, A., Huth-Kuehne, A. & Morfini, M. (2004) Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann’s thrombasthenia: results of an international survey. Journal of Thrombosis & Haemostasis, 2, 10961103.
  • Prabu, P. & Parapia, L.A. (2006) Bernard–Soulier Syndrome in pregnancy. Clinical and Laboratory Haematology, 28, 198201.
  • Rahimi, G., Rellecke, S., Mallmann, P. & Nawroth, F. (2005) Course of pregnancy and birth in a patient with Bernard–Soulier syndrome--a case report. Journal of Perinatal Medicine, 33, 264266.
  • Rao, A.K., Ghosh, S., Sun, L., Yang, X., Disa, J., Pickens, P. & Polansky, M. (1995) Mechanisms of platelet dysfunction and reponse to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial. Thrombosis and Haemostasis, 74, 10711078.
  • Rieger, C., Rank, A., Fiegl, M., Tischer, J., Schiel, X., Ostermann, H. & Kolb, H. (2006) Allogeneic stem cell transplantation as a new treatment for patients with severe Bernard–Soulier Syndrome. Thrombosis and Haemostasis, 95, 190191.
  • Saade, G., Homsi, R. & Seoud, M. (1991) Bernard–Soulier Syndrome in pregnancy; a report of four pregnancies in one patient, and review of the literature. European Journal of Obstetrics and Gynaecology, 40, 149152.
  • Sherer, D.M. & Lerner, R. (1999) Glanzmann’s thrombasthenia in pregnancy: a case and review of the literature. American Journal of Perinatology, 16, 297301.
  • Simon, D., Kunicki, T. & Nugent, D. (2008) Platelet function defects. Haemophilia, 14, 12401249.
  • Sugihara, S., Katsutani, S., Hyodo, H., Hyodo, M., Kudo, Y., Fujii, T. & Kimura, A. (2008) Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia. Rinsho Ketsueki, 49, 4650.
  • Tengborn, L. & Petruson, B. (1996) A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thrombosis and Haemostasis, 75, 981982.
  • Tsementzis, S.A. & Marsh, J. (1991) Spontaneous subarachnoid haemorrhage occurring in association with a platelet function disorder. Neurosurgical Review, 14, 5759.
  • Uotila, J., Tammela, O. & Mäkipernaa, A. (2008) Fetomaternal platelet immunization associated with maternal Bernard–Soulier syndrome. American Journal of Perinatology, 25, 219223.
  • Vettore, S., Scandellari, R., Moro, S., Lombardi, A.M., Scapin, M., Randi, M.L. & Fabris, F. (2008) Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard–Soulier syndrome affecting two unrelated families: the N41H variant. Haematologica, 93, 17431747.
  • Vijapurkar, M., Mota, L., Shetty, S. & Ghosh, K. (2009) Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent. Haemophilia, 15, 199202.
  • Vivier, M., Treisser, A., Naett, M., Diemunsch, P., Schmitt, J.P., Waller, C., Tongio, M.M., Hemmendinger, S. & Lutz, P. (1989) Glanzmann’s thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled caesarean section. Journal de gynecologie, obstetrique etbiologie de la reproduction, 18, 507513.
  • Ware, J., Russell, S.R. & Vicente, V. (1990) Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard–Soulier syndrome. Proceedings of the National Academy of Sciences of the United States of America, 87, 20262030.
  • Wijermans, P.W. & Van Dorp, D.B. (1989) Hermansky-Pudlak syndrome: correction of bleeding time by 1-desamino-8D-arginine vasopressin. American Journal of Hematology, 30, 154157.
  • Wilcox, D.A. & White, G.C. (2003) Gene therapy for platelet disorders: studies with Glanzmann’s thrombasthenia. Journal of Thrombosis and Haemostasis, 1, 23002311.
  • Wilcox, D.A., Olsen, J.C., Ishizawa, L., Griffith, M. & White, G.C. II (1999) Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America, 96, 96549659.
  • Wilcox, D.A., Olsen, J.C. & Ishizawa, L. (2000) Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia. Blood, 95, 36453651.
  • Zatik, J., Póka, R., Borsos, A. & Pfliegler, G. (2002) Variable response of Hermansky-Pudlak syndrome to prophylactic administration of 1-desamino 8D-arginine in subsequent pregnancies. European Journal of Obstetrics, Gynecology and Reproductive Biology, 104, 165166.